Hepatitis Monthly

Published by: Kowsar

Seroprevalence of Hepatitis A among Children and Young Adults Residing in Tehran, Iran: Implication for HAV Vaccination

Amitis Ramezani 1 , Mohammad Reza Aghasadeghi 2 , Setareh Mamishi 3 , Shahram Sabeti 4 , Farahnaz Bidari - Zerehpoosh 4 , Mohammad Banifazl 5 , Anahita Bavand 1 , Sahar Shadanlou 1 and Arezoo Aghakhani 1 , *
Authors Information
1 Clinical Research Department, Pasteur Institute of Iran, Tehran, Iran
2 Hepatitis & AIDS Department, Pasteur Institute of Iran, Tehran, Iran
3 Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
4 Pathology Ward, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5 Iranian Society for Support of Patients with Infectious Diseases, Tehran, Iran
Article information
  • Hepatitis Monthly: April 2018, 18 (4); e66915
  • Published Online: May 12, 2018
  • Article Type: Research Article
  • Received: January 30, 2018
  • Revised: April 24, 2018
  • Accepted: April 28, 2018
  • DOI: 10.5812/hepatmon.66915

To Cite: Ramezani A, Aghasadeghi M R, Mamishi S, Sabeti S, Bidari - Zerehpoosh F, et al. Seroprevalence of Hepatitis A among Children and Young Adults Residing in Tehran, Iran: Implication for HAV Vaccination, Hepat Mon. 2018 ; 18(4):e66915. doi: 10.5812/hepatmon.66915.

Copyright © 2018, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: Epidemiology and prevention in developing countries. World J Hepatol. 2012;4(3):68-73. doi: 10.4254/wjh.v4.i3.68. [PubMed: 22489258]. [PubMed Central: PMC3321492].
  • 2. World Health Organization. Hepatitis A vaccines. Wkly Epidemiol Rec. 2000;75(5):38-44. [PubMed: 10693358].
  • 3. Vilibic-Cavlek T, Kucinar J, Ljubin-Sternak S, Kolaric B. Seroepidemiology of hepatitis a in the croatian population. Hepat Mon. 2011;11(12):997-9. doi: 10.5812/kowsar.1735143X.756. [PubMed: 22368685]. [PubMed Central: PMC3282034].
  • 4. Jacobsen KH, Koopman JS. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol. 2005;34(3):600-9. doi: 10.1093/ije/dyi062. [PubMed: 15831565].
  • 5. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28(41):6653-7. doi: 10.1016/j.vaccine.2010.08.037. [PubMed: 20723630].
  • 6. Cuthbert JA. Hepatitis A: old and new. Clin Microbiol Rev. 2001;14(1):38-58. doi: 10.1128/CMR.14.1.38-58.2001. [PubMed: 11148002]. [PubMed Central: PMC88961].
  • 7. Ciocca M. Clinical course and consequences of hepatitis A infection. Vaccine. 2000;18 Suppl 1:S71-4. [PubMed: 10683554].
  • 8. Letaief A, Kaabia N, Gaha R, Bousaadia A, Lazrag F, Trabelsi H, et al. Age-specific seroprevalence of hepatitis a among school children in central Tunisia. Am J Trop Med Hyg. 2005;73(1):40-3. [PubMed: 16014829].
  • 9. Melnick JL. History and epidemiology of hepatitis A virus. J Infect Dis. 1995;171 Suppl 1:S2-8. [PubMed: 7876643].
  • 10. Hosseini Shokouh SJ, Dadashi A, Abiri M, Zohrevand I, Eshraghian A, Khoshdel A, et al. HAV Immunity in Iranian Medical Students. Hepat Mon. 2015;15(3). e26219. doi: 10.5812/hepatmon.26219. [PubMed: 25825590]. [PubMed Central: PMC4359362].
  • 11. Yun H, Lee HJ, Yoon Y, Kim K, Kim S, Shin MH, et al. Seroepidemiology of hepatitis a infection in northeastern china, Korea, and Japan. Osong Public Health Res Perspect. 2012;3(1):31-5. doi: 10.1016/j.phrp.2012.01.005. [PubMed: 24159484]. [PubMed Central: PMC3738681].
  • 12. World Health Organization. WHO position paper on hepatitis A vaccines. Wkly Epidemiol Rec. 2012;87:261-76. [PubMed: 22905367].
  • 13. Montazam SH, Kafshounchi M, Tanoumand A. [Age-specific prevalence of antibodies to hepatitis A in rural and urban population of Malekan city]. Medical Science Journal of Islamic Azad Univesity-Tehran Medical Branch. 2007;17(1):41-4. Persian.
  • 14. Ataei B, Nokhoudian Z, Javadi AA, Kasaeian N, Farajzadegan Z, Shoaei P, et al. [Seroepidemiology of hepatitis A virus infections in Over 6-years population in Isfahan–Iran: A community-based study]. J Isfahan Med Sch. 2007;25:46-73. Persian.
  • 15. Saffar MJ, Abedian O, Ajami A, Abedian F, Mirabi AM, Khalilian AR, et al. Age-specific seroprevalence of anti-hepatitis a antibody among 1-30 years old population of savadkuh, mazandaran, iran with literature review. Hepat Mon. 2012;12(5):326-32. doi: 10.5812/hepatmon.6035. [PubMed: 22783344]. [PubMed Central: PMC3389358].
  • 16. Farajzadegan Z, Hoseini SG, Kelishadi R, Jamshidi F, Nokhodian Z, Noori R, et al. Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran. J Res Med Sci. 2014;19(Suppl 1):S56-63. [PubMed: 25002897]. [PubMed Central: PMC4078371].
  • 17. European Centre for Disease Prevention and Control. Hepatitis A virus in the EU/EEA, 1975-2014. Stockholm: ECDC; 2016.
  • 18. Abdolvahab M, Behnaz K, Sima B, M T. Hepatitis a in young adults in the golestan province, northeast of iran. J Glob Infect Dis. 2010;2(2):198-9. doi: 10.4103/0974-777X.62862. [PubMed: 20606982]. [PubMed Central: PMC2889666].
  • 19. Mostafavi N, Kelishadi R, Kazemi E, Ataei B, Yaran M, Motlagh ME, et al. Comparison of the Prevalence and Risk Factors of Hepatitis A in 10 to 18-Year-Old Adolescents of Sixteen Iranian Provinces: The CASPIAN-III Study. Hepat Mon. 2016;16(9). e36437. doi: 10.5812/hepatmon.36437. [PubMed: 27822259]. [PubMed Central: PMC5091029].
  • 20. Merat S, Rezvan H, Nouraie M, Abolghasemi H, Jamali R, Amini-Kafiabad S, et al. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med. 2010;13(2):99-104. [PubMed: 20187662].
  • 21. Mohebbi SR, Rostami Nejad M, Tahaei SM, Pourhoseingholi MA, Habibi M, Azimzadeh P, et al. Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study. Trans R Soc Trop Med Hyg. 2012;106(9):528-31. doi: 10.1016/j.trstmh.2012.05.013. [PubMed: 22835757].
  • 22. Noroozi M, Moradi F, Hasanzadeh A, Banazadegan R, Basiri MR, Ramezani A, et al. [Seroprevalence of hepatitis A and hepatitis E in Qom province, 2011]. Iran J Infect Dis Trop Med. 2012;17(58):19-23. Persian.
  • 23. Taghavi SA, Hosseini Asl MK, Talebzadeh M, Eshraghian A. Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon. 2011;11(4):285-8. [PubMed: 22706273]. [PubMed Central: PMC3206696].
  • 24. Farzadegan H, Shamszad M, Noori-Arya K. Epidemiology of viral hepatitis among Iranian population--a viral marker study. Ann Acad Med Singapore. 1980;9(2):144-8. [PubMed: 7425524].
  • 25. Saffar MJ, Hemmatabady M. [Hepatitis A Seroepidemiology among 1-15 years old children in Sari Iran 1997]. Mazandaran Univ Med Sci J. 1999;9(22-23):1-6. Persian.
  • 26. Khodaei E. Hepatitis A seroepidemiology in Tehranian children less than 14 years old. 7th Congress of Infectious Diseases and Tropical Medicine. Babolsar. 1998. 33 p.
  • 27. Salehi M, Sanei Moghaddam E. [Seroepidemiology of Hepatitis A in population under 30-years-old in rural areas of Zabol]. Guil Univ Med Sci J. 2001;10(37-38):26-9. Persian.
  • 28. Ataei B, Javadi AA, Nokhodian Z, Kassaeian N, Shoaei P, Farajzadegan Z, et al. HAV in Isfahan province: a population-based study. Trop Gastroenterol. 2008;29(3):160-2. [PubMed: 19115608].
  • 29. Sofian M, Aghakhani A, Farazi AA, Banifazl M, Etemadi G, Azad-Armaki S, et al. Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: implications for health policy. Travel Med Infect Dis. 2010;8(3):176-9. doi: 10.1016/j.tmaid.2010.02.004. [PubMed: 20541138].
  • 30. Elizee PK, Alavian SM. Prevention of hepatitis a virus infection, need to vaccinate or not? Int J Prev Med. 2013;4(8):863-5. [PubMed: 24049610]. [PubMed Central: PMC3775161].
  • 31. Salahei M, Ansari Moghaddam A, Sanei Moghaddam E, Khosravi S, Hajibeigi B, Alavian SM. The epidemiological pattern of acute viral hepatitis in Tehran and Zahedan: A comparison study. Gastroenterol Hepatol from bed to bench. 2009;3(1):33-6. doi: 10.22037/ghfbb.v3i1.67.
  • 32. Movahedi M, Haghdoost AA, Pournik O, Hajarizadeh B, Fallah MS. Temporal variations of health indicators in Iran comparing with other Eastern Mediterranean Region countries in the last two decades. J Public Health (Oxf). 2008;30(4):499-504. doi: 10.1093/pubmed/fdn071. [PubMed: 18772146].
  • 33. Lednar WM, Lemon SM, Kirkpatrick JW, Redfield RR, Fields ML, Kelley PW. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol. 1985;122(2):226-33. [PubMed: 3860002].
  • 34. Tseng SL, Hsieh YC, Huang YL, Huang YC, Hung YT, Huang YC. Hepatitis A virus seroepidemiology of elementary school children in New Taipei City in Taiwan. J Microbiol Immunol Infect. 2016;49(5):743-8. doi: 10.1016/j.jmii.2014.08.022. [PubMed: 25442870].
  • 35. Vancelik S, Guraksin A, Alp H. Hepatitis A seroepidemiology in Eastern Turkey. East Afr Med J. 2006;83(2):86-90. [PubMed: 16708879].
  • 36. Tsai CF, Lin DB, Chen SC, Chang YH, Chen CY, Lin JB. Seroepidemiology of hepatitis A virus infection among schoolchildren in Taiwan. J Med Virol. 2011;83(2):196-200. doi: 10.1002/jmv.22000. [PubMed: 21181912].
  • 37. Al-Aziz AM, Awad MA. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children. East Mediterr Health J. 2008;14(5):1028-35. [PubMed: 19161074].
  • 38. Campagna M, Maria Mereu N, Mulas L, Pilia R, Francesca Piazza M, Spada L, et al. Pattern of Hepatitis A Virus Epidemiology in Nursing Students and Adherence to Preventive Measures at Two Training Wards of a University Hospital. Hepat Mon. 2016;16(2). e34219. doi: 10.5812/hepatmon.34219. [PubMed: 27195012]. [PubMed Central: PMC4867361].
  • 39. Hoseini SG, Kelishadi R, Ataei B, Yaran M, Motlagh ME, Ardalan G, et al. Seroprevalence of hepatitis A in Iranian adolescents: is it time to introduce a vaccine? Epidemiol Infect. 2016;144(2):291-6. doi: 10.1017/S0950268815001302. [PubMed: 26083105].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments